EDIT vs. SPY
Compare and contrast key facts about Editas Medicine, Inc. (EDIT) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EDIT or SPY.
Key characteristics
| EDIT | SPY | |
|---|---|---|
| YTD Return | -62.88% | 23.95% |
| 1Y Return | -40.22% | 40.44% |
| 3Y Return (Ann) | -53.86% | 10.47% |
| 5Y Return (Ann) | -29.07% | 16.08% |
| Sharpe Ratio | -0.56 | 3.15 |
| Sortino Ratio | -0.58 | 4.18 |
| Omega Ratio | 0.94 | 1.58 |
| Calmar Ratio | -0.43 | 3.32 |
| Martin Ratio | -0.92 | 20.89 |
| Ulcer Index | 45.13% | 1.85% |
| Daily Std Dev | 73.78% | 12.23% |
| Max Drawdown | -96.73% | -55.19% |
| Current Drawdown | -95.85% | -0.16% |
Correlation
The correlation between EDIT and SPY is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
EDIT vs. SPY - Performance Comparison
In the year-to-date period, EDIT achieves a -62.88% return, which is significantly lower than SPY's 23.95% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
EDIT vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Editas Medicine, Inc. (EDIT) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
EDIT vs. SPY - Dividend Comparison
EDIT has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.20%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EDIT Editas Medicine, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.20% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% | 1.81% |
Drawdowns
EDIT vs. SPY - Drawdown Comparison
The maximum EDIT drawdown since its inception was -96.73%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for EDIT and SPY. For additional features, visit the drawdowns tool.
Volatility
EDIT vs. SPY - Volatility Comparison
Editas Medicine, Inc. (EDIT) has a higher volatility of 20.08% compared to SPDR S&P 500 ETF (SPY) at 2.52%. This indicates that EDIT's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.